Log In
Print
BCIQ
Print
Print this Print this
 

Viibryd, vilazodone

Also known as: EMD 68843, SB 659746-A

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionMixed selective serotonin reuptake inhibitor (SSRI) and partial serotonin (5-HT1A) receptor agonist
Molecular Target Serotonin (5-HT) receptor ; Serotonin (5-HT1A) receptor
Mechanism of ActionSelective serotonin reuptake inhibitor (SSRI); Serotonin (5-HT1A) receptor partial agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$282.0M

0

$125.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today